Hepatic Presentation of Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency (MADD): Case Report and Systematic Review
Open Access
- 10 May 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pediatrics
Abstract
Diagnosis of pediatric steatohepatitis is a challenging issue due to a vast number of established and novel causes. Here, we report a child with Multiple Acyl-CoA Dehydrogenase Deficiency (MADD) presenting with an underrated muscle weakness, exercise intolerance and an atypically severe steatotic liver involvement. A systematic literature review of liver involvement in MADD was performed as well. Our patient is a 11-year-old otherwise healthy, non-obese, male child admitted for some weakness/asthenia, vomiting and recurrent severe hypertransaminasemia (aspartate and alanine aminotransferases up to ×20 times upper limit of normal). Hepatic ultrasound showed a bright liver. MRI detected mild lipid storage of thighs muscles. A liver biopsy showed a micro-macrovacuolar steatohepatitis with minimal fibrosis. Main causes of hypertransaminasemia were ruled out. Serum aminoacids (increased proline), acylcarnitines (increased C4-C18) and a large excretion of urinary glutaric acid, ethylmalonic, butyric, isobutyric, 2-methyl-butyric and isovaleric acids suggested a diagnosis of MADD. Serum acylcarnitines and urinary organic acids fluctuated overtime paralleling serum transaminases during periods of illness/catabolic stress, confirming their recurrent nature. Genetic testing confirmed the diagnosis [homozygous c.1658A > G (p.Tyr553Cys) in exon 12 of the ETFDH gene]. Lipid-restricted diet and riboflavin treatment rapidly ameliorated symptoms, hepatic ultrasonography/enzymes, and metabolic profiles. Literature review (37 retrieved eligible studies, 283 patients) showed that liver is an extramuscular organ rarely involved in late-onset MADD (70 patients), and that amongst 45 patients who had fatty liver only nine had severe presentation. Conclusion: MADD is a disorder with a clinically heterogeneous phenotype. Our study suggests that MADD warrants consideration in the work-up of obesity-unrelated severe steatohepatitis.This publication has 48 references indexed in Scilit:
- Diagnosis of Nonalcoholic Fatty Liver Disease in Children and AdolescentsJournal of Pediatric Gastroenterology and Nutrition, 2012
- Novel ETF dehydrogenase mutations in a patient with mild glutaric aciduria type II and complex II‐III deficiency in liver and muscleJournal of Inherited Metabolic Disease, 2010
- High frequency of ETFDH c.250G>A mutation in Taiwanese patients with late‐onset lipid storage myopathyClinical Genetics, 2010
- Diagnosis, Treatment, and Long-Term Outcomes of Late-Onset (Type III) Multiple Acyl-CoA Dehydrogenase DeficiencyJournal of Child Neurology, 2009
- Riboflavin-responsive lipid-storage myopathy caused by ETFDH gene mutationsJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Clinical and genetic analysis of lipid storage myopathiesMuscle & Nerve, 2009
- Clinical and molecular investigations of Japanese cases of glutaric acidemia type 2Molecular Genetics and Metabolism, 2008
- The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) geneBrain, 2007
- Riboflavin-responsive glutaric aciduria type II with recurrent pancreatitisPediatric Neurology, 2004
- Clear relationship betweenETF/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation deficiencyHuman Mutation, 2003